Senior insider sale
Chief Scientific Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$13.6K
3.52K shares
What this filing means
CARTER TODD ALFRED plans to sell 3.52K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $13.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/10/2026ACC: 0001959173-26-000817
Officer· Chief Scientific Officer
Since Feb 2026
3.52K
Shares to sell
$13.6K
Approx. market value
3.52K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/9/2026
3.52KTotal acquired3.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/9/2026 | Restricted Stock Vesting Compensation | 3.52K | — |
| Total | 3.52K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.52K
Market value
$13.6K
2/10/2026
Total
Units
3.52K
Value
$13.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/10/2026 | 3.52K | $13.6K | NASDAQ | Planned |
| Total | 3.52K | $13.6K | ||